159 related articles for article (PubMed ID: 23070122)
1. Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma.
Sun R; Qiu HZ; Mai HQ; Zhang Q; Hong MH; Li YX; Yang J; Sun J; Mo HY
J Cancer Res Clin Oncol; 2013 Feb; 139(2):307-14. PubMed ID: 23070122
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
3. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
[TBL] [Abstract][Full Text] [Related]
4. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 7th Edition of AJCC Staging System for Nasopharyngeal Carcinoma.
Ren Y; Qiu H; Yuan Y; Ye J; Tian Y; Wen B; Zhang W; Li Q
J Cancer; 2017; 8(9):1665-1672. PubMed ID: 28775786
[No Abstract] [Full Text] [Related]
8. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
Chen L; Mao YP; Xie FY; Liu LZ; Sun Y; Tian L; Tang LL; Lin AH; Li L; Ma J
Radiother Oncol; 2012 Sep; 104(3):331-7. PubMed ID: 22103978
[TBL] [Abstract][Full Text] [Related]
9. A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.
Zhou Q; He Y; Zhao Y; Wang Y; Kuang W; Shen L
Biomed Res Int; 2017; 2017():1419676. PubMed ID: 28265567
[TBL] [Abstract][Full Text] [Related]
10. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
[TBL] [Abstract][Full Text] [Related]
11. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
12. Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.
Li Y; Ou X; Hu C
Jpn J Clin Oncol; 2018 Oct; 48(10):927-933. PubMed ID: 30113640
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
[No Abstract] [Full Text] [Related]
14. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Kang M; Zhou P; Liao X; Xu M; Wang R
Oral Oncol; 2017 Dec; 75():100-105. PubMed ID: 29224805
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
Liang SB; Deng YM; Zhang N; Lu RL; Zhao H; Chen HY; Li SE; Liu DS; Chen Y
BMC Cancer; 2013 May; 13():260. PubMed ID: 23710879
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.
Mao YP; Xie FY; Liu LZ; Sun Y; Li L; Tang LL; Liao XB; Xu HY; Chen L; Lai SZ; Lin AH; Liu MZ; Ma J
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1326-34. PubMed ID: 19153016
[TBL] [Abstract][Full Text] [Related]
19. Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?
Sze H; Chan LL; Ng WT; Hung AW; Lee MC; Chang AT; Chan OS; Cheung FY; Yeung RM; Lee AW
Oral Oncol; 2014 Dec; 50(12):1188-95. PubMed ID: 25261296
[TBL] [Abstract][Full Text] [Related]
20. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
